Miklos Udvardy

Q: What Schools Are Affiliated With Miklos Udvardy

Miklos Udvardy is affiliated with the following schools: University of California, Santa Barbara, University of Oxford, University of Debrecen, University of British Columbia, University of California, Los Angeles, Semmelweis University, Cornell University, University of Bonn, University of Helsinki

Miklos Udvardy's AcademicInfluence.com Rankings

Miklos Udvardy

Biology

#777

World Rank

#1344

Historical Rank

Zoology

#51

World Rank

#171

Historical Rank

biology Degrees

Download Badge

Biology

Miklos Udvardy's Degrees

PhD Ornithology Cornell University
Masters Zoology Cornell University
Bachelors Zoology Cornell University

Why Is Miklos Udvardy Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Miklos Dezso Ferenc Udvardy was a Hungarian-born Canadian biologist and professor at the University of British Columbia. He made significant contributions to various fields, including biogeography, evolutionary biology, ornithology, and vegetation classification. Udvardy published 191 papers and books including an influential text on zoogeography.

(See a Problem?)

Miklos Udvardy's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Shielding of the A1 Domain by the D′D3 Domains of von Willebrand Factor Modulates Its Interaction with Platelet Glycoprotein Ib-IX-V* (2006) (131)
Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients (2007) (86)
The possible association of in vivo leukocyte-platelet heterophilic aggregate formation and the development of diabetic angiopathy (2001) (65)
Changes in the expression and distribution of the inducible and endothelial nitric oxide synthase in mucosal biopsy specimens of inflammatory bowel disease (2005) (61)
The association of reduced endothelium derived relaxing factor-NO production with endothelial damage and increased in vivo platelet activation in patients with diabetes mellitus. (1997) (55)
Clinical and Immunoserological Characteristics of Mixed Connective Tissue Disease Associated with Pulmonary Arterial Hypertension (2006) (54)
[Bacterial infections in liver cirrhosis]. (2007) (44)
The most severe forms of Perthes' disease associated with the homozygous Factor V Leiden mutation. (2004) (35)
Reduced in vitro clot lysis and release of more active platelet PAI-1 in polycythemia vera and essential thrombocythemia. (1998) (34)
Promotion of the Crosslinking of Fibrin and α2-antiplasmin by Platelets (1996) (33)
Plasma levels of beta-thromboglobulin and factor VIII-related antigen in diabetic children and adults. (1983) (32)
Thrombotic and fibrinolytic alterations in the aseptic necrosis of femoral head (2003) (26)
Haptoglobin Polymorphisms Are Associated with Crohn’s Disease, Disease Behavior, and Extraintestinal Manifestations in Hungarian Patients (2007) (25)
Changes in oncogene expression implicated in evolution of chronic granulocytic leukemia from its chronic phase to acceleration. (1998) (23)
Plasma thromboxane and prostacyclin metabolite ratio in atherosclerosis and diabetes mellitus. (1987) (23)
Glucose intolerance and insulin resistance with aging--studies on insulin receptors and post-receptor events. (1987) (22)
Effect of IBD sera on expression of inducible and endothelial nitric oxide synthase in human umbilical vein endothelial cells. (2006) (21)
Platelet insulin receptor determination in non-insulin dependent diabetes mellitus (1985) (21)
Increased leukocyte-platelet adhesion in chronic myeloproliferative disorders with high platelet counts. (2000) (20)
Promotion of the crosslinking of fibrin and alpha 2-antiplasmin by platelets. (1996) (16)
Successful control of massive coumarol-induced acute upper gastrointestinal bleeding and correction of prothrombin time by recombinant active factor VII (Eptacog-alpha, NovoSeven) in a patient with a prosthetic aortic valve and two malignancies (chronic lymphoid leukaemia and lung cancer). (2004) (16)
Cyclophosphamide for chronic relapsing thrombotic thrombocytopenic purpura (1990) (14)
Shielding of the A 1 Domain by the D D 3 Domains of von Willebrand Factor Modulates Its Interaction with Platelet Glycoprotein (2006) (13)
Effect of L-arginine on in vitro plasmin-generation and fibrinogenolysis. (1996) (12)
[Successful alemtuzumab treatment of a patient with atypical hairy cell leukaemia variant]. (2007) (11)
Endothelium releases more von Willebrand factor and tissue-type plasminogen activator upon venous occlusion in patients with liver cirrhosis than in normals. (1993) (11)
Hybrid peptide containing RGDF (Arg‐Gly‐Asp‐Phe) coupled with the carboxyterminal part of α2-antiplasmin capable of inhibiting platelet aggregation and promoting fibrinolysis (1995) (11)
Presence and Possible Origin of ɛ(γ-Glutamyl)Lysine Isodipeptide in Human Plasma (1992) (10)
Increased platelet activation and decreased fibrinolysis in the pathogenesis of aseptic necrosis of the femoral head. (1998) (9)
Differential platelet deposition onto collagen in cone-and-plate and parallel plate flow chambers (2006) (9)
[Hematologic aspects of inflammatory bowel diseases]. (2001) (8)
Increased in vivo platelet activation and reduced intravascular endothelium-derived relaxing factor and nitrate/nitrite production in patients with insulin-dependent diabetes mellitus. (1998) (8)
Platelet function studies in myeloproliferative disorders. (1986) (7)
Pgp and FLT3: identification and modulation of two proteins that lead to chemotherapy resistance in acute myeloid leukemia. (2007) (7)
Thrombotic Changes in Haemostasis Following Intravenous Streptokinase Treatment for Acute Myocardial Infarction (1990) (7)
Effects of in vitro platelet activation on platelet derived nitric oxide production in healthy humans and in chronic myeloproliferative diseases with elevated platelet counts (2003) (6)
[Cerebral deep vein thrombosis associated with rectal cancer]. (2000) (6)
[Haptoglobin polymorphism in patients with inflammatory bowel diseases]. (2006) (6)
Hepatic actions of progestogenic steroids. (1984) (5)
[Prognositc value of CD38 cell surface marker in chronic lymphocytic leukemia]. (2003) (4)
Effect of calcium dobesilate treatment on haemostasis and serum lipids in diabetic patients (1986) (4)
Alterations of primary haemostasis in mixed connective tissue disease (MCTD). (1991) (4)
Altered lysis resistance of platelet-rich clots in patients with insulin-dependent diabetes mellitus. (1995) (4)
RGDFAP: platelet aggregation inhibitory and profibrinolytic hybrid peptide (RGDF coupled with the carboxy terminal part of alpha 2-antiplasmin) enhances plasminogen binding to platelets. (1995) (4)
Beta thromboglobulin and increased platelet activation after streptokinase treatment of acute myocardial infarction. (1992) (4)
[Hemostatic abnormalities in ischemic stroke]. (1998) (3)
[Immune thrombocytopenic purpura (ITP)]. (2001) (3)
Systemic inflammatory response syndrome (SIRS) induced by carbon tetrachloride in rats (1997) (3)
[The pathophysiology, clinical signs and therapy of urate nephropathy]. (2007) (3)
Enzymatic fluorimetric assay for ϵ(γ-glutamyl)lysine isodipeptides A new assay for proteolytic fragments of proteins cross-linked by factor XIII and other transglutaminases (1994) (3)
[New perspectives in the evolution of prognosis and treatment of chronic lymphocytic leukaemia]. (2004) (3)
Chromosomal aberrations and CD38 expression in two siblings with B-cell chronic lymphocytic leukemia: A report of two siblings (2005) (3)
Cyclic relapses of thrombotic thrombocytopenic purpura. (1994) (3)
Immediate eradication of helicobacter pylori infection seems to be beneficial compared to solely “PPI” treatment in the management of bleeding duodenal ulcer (2000) (2)
P093 Zevalin-BEAM conditioning therapy for autologous peripheral stem cell transplantation (PSCT) in patients with follicular non-Hodgkin lymphoma (2007) (2)
Serum alpha-fetoprotein in chronic liver disease. (1983) (2)
[Changes in hematologic and hemostatic parameters after transjugular intrahepatic portosystemic shunt (TIPS) implantation]. (2003) (2)
[Experience with fludarabine treatment and review of the literature]. (2002) (2)
[Chronic neutrophilic leukemia: a long-term analysis of seven cases and review of the literature]. (2006) (2)
The use of polybrene for heparin neutralization in protein C activity assay (1990) (1)
[Primary treatment of advanced Hodgkin's disease]. (2005) (1)
[Anti-adhesive and anti-thrombotic effects of integrin-inhibiting tripeptides (Arg-Gly-Asp)]. (1995) (1)
P096 After the 100th autologous peripheral haemopoietic stem cell transplantation in the 2nd Department of the Medicine, University of Debrecen, Hungary (2007) (1)
[Gastroesophageal variceal haemorrhage--new advances in pathophysiology]. (2006) (1)
Altered primary haemostasis in Conn's syndrome. (1992) (1)
Possible role for platelet insulin receptors in modulating platelet function in health and diabetes mellitus. (1993) (1)
[New possibilities in the management of hemorrhagic diathesis caused by factor deficiency and thrombocytopenia: recombinant active factor VII concentrate]. (1998) (1)
Acromegaly with cavernous haemangioma of the liver and colonic polyps. (1995) (1)
88. in vitro clot-lysis in the presence of cultured human umbilical vein endothelial cells, experiences in diabetes mellitus and liver cirrhosis (1996) (1)
[Detection of Helicobacter pylori in tissue samples of stomach cancer]. (1999) (1)
Sex differences and sex hormones in experimental liver injury. (1979) (1)
[Clinical aspects of heparin induced thrombocytopenia]. (1999) (1)
O06 Bortezomib+chemotherapy based salvage combinations in refractory AML, preliminary results (2007) (1)
P035 Implementation of the ISLH criteria for action following automated CBC and WBC differential analysis (2007) (0)
[Heparin-induced thrombocytopenia]. (1978) (0)
[Individualized streptokinase treatment of acute myocardial infarct]. (1990) (0)
Markers of fibrogenesis in patients with chronic hepatitis C (2000) (0)
The regulation of von Willebrand factor A1 domain GPIb-IX-V interaction (2005) (0)
[Gastric MALT lymphoma, clinical features]. (1999) (0)
P017 Transfusion associated GVHD and lymphoma after autologous stem cell transplantation in a patient with multiple myeloma (2007) (0)
Blood glucose and diabetic retinopathy. (1992) (0)
[Hemostasis in liver diseases]. (2000) (0)
[Significance of the determination of beta-thromboglobulin. Experience with coronary sclerosis, and diabetes]. (1983) (0)
[New agents and challenges in the antithrombotic management of arterial diseases]. (1997) (0)
[Nitrogen monoxide (NO) in the function of the gastrointestinal tract and the liver]. (1997) (0)
[Study of hemostasis in chronic kidney failure patients with special reference to immune complex positive and negative cases]. (1978) (0)
[Fibrinolysis and vascular diseases]. (1996) (0)
[In memoriam: Kálmán Rák (1929-2005) - Imre Hirschler (1906-1989)]. (2007) (0)
[Disseminated intravascular coagulation(DIC)]. (2001) (0)
Atherosclerosis and prostaglandin: Is the primary haemostasis of patients with advanced atherosclerosis profoundly altered? (1986) (0)
P160 Alemtuzumab-induced apoptosis in vitro in chronic lymphocytic leukemia with p53 deletion (2007) (0)
P168 Hepatitis B virus reactivation in a case of non-Hodgkin's lymphoma treated with immuno-chemotherapy (including fludarabine and rituximab) (2007) (0)
P037 Haptoglobin polymorphism in patients with chronic lymphocytic leukemia (2007) (0)
Current state of the somatostatin research (Hungarian) (1977) (0)
[Syncumar or low doses of heparin in the prevention of thromboembolism in acute myocardial infarct?]. (1981) (0)
[Serum alpha-1 fetoprotein in chronic liver diseases]. (1982) (0)
P111 Glivec treatment in the 2nd Department of Medicine, University of Debrecen, Hungary (2000 2007) (2007) (0)
Immunohystochemical study of nitric oxide synthase's (NOS) activity in IBD colonic mucosa (2000) (0)
[Current status of the management of upper gastrointestinal hemorrhage at a specialized hospital unit]. (1998) (0)
Study of shear-dependent platelet aggregation in patients with low and high von Willebrand factor plasmatic level (1992) (0)
[Expanding possibilities, strategic considerations, and novel methods in the diagnosis and chemotherapy of adult acute myeloid leukemia]. (2003) (0)
P158 Alemtuzumab for the treatment of hairy cell leukemia and atypical hairy cell leukemia variant; report of two cases (2007) (0)
[Pure red cell aplasia, associated with chronic lymphoid leukemia, successfully treated with closorine]. (1997) (0)
[Acute gastrointestinal bleeding in patients with antithrombotic therapy]. (2002) (0)
The involvement of platelets and platelet factor xiii in the crosslinking of fibrin and α2 antiplasmin (1996) (0)
[The lupus anticoagulant and its clinical significance]. (1989) (0)
[The value of the gamma-glutamyl-transpeptidase study in acute hepatitis]. (1978) (0)
Effect of Activated Recombinant Coagulation Factor VII on the Function of Glycoprotein IIb/IIIa-Inhibited Platelets in Vitro (2006) (0)
Data on the glucagon's role, its effects on the metabolism and its clinical importance (Hungarian) (1976) (0)
[Thrombotic changes in hemostasis following streptokinase therapy in myocardial infarct]. (1990) (0)
[Connection between plasma thromboxane and prostacyclin levels in the metabolic control of diabetic children]. (1989) (0)
[Changes in hemostasis in diabetes mellitus]. (1982) (0)
New pentamidine related substances which simultaneously inhibit platelet aggregation and accelerate plasmin generation and in vitro clot lysis. (1996) (0)
Follow up and treatment of patients with chronic hepatitis C (1993–1997) (1998) (0)
[Wolfram syndrome]. (1980) (0)
[Anticoagulant and platelet-inhibition therapy of patients with artificial heart valves]. (1987) (0)
LONG-TERM COUMAROL PLUS SMALL DOSE ASA THERAPY IN PATIENTS WITH PROSTHETIC HEART VALVE. SOME QUESTIONS OF LABORATORY CONTROL (1987) (0)
[Correlation between adhesive factors of primary hemostasis and liver fibrogenesis in alcoholic live cirrhosis]. (1994) (0)
[Fibrinolysis studied by an in vitro clot lysis test in polycythemia vera]. (1996) (0)
[Diabetes mellitus and fibrinolysis (experience with an in vitro clot lysis test)]. (1994) (0)
P019 Regulatory T cell (Treg) reconstitution following high-dose chemotherapy and autologous stem cell transplant in multiple myeloma, palifermin (Kepivance) may accelerate early Treg response, preliminary results (2007) (0)
[Primary hemostasis in mixed connective tissue disease]. (1991) (0)
36. Prospective determination of fibrinogen of patients on long-term coumarin or coumarin plus low dose ASA therapy (1996) (0)
Autologous Bone Marrow-Derived Stem Cell Therapy in Patients with Severe Peripheral Arterial Disorders: A Pilot Study. (2007) (0)
[Simultaneous occurrence of Sheehan syndrome and Willebrand disease]. (1988) (0)
[The role of alpha-interferon therapy in chronic myeloid leukemia]. (2000) (0)
[Paroxysmal nocturnal hemoglobinuria]. (2002) (0)
[Plasma thromboxane and prostacyclin metabolite ratio in atherosclerosis and diabetic angiopathy]. (1986) (0)
Haemostasis in diabetics. (1984) (0)
P010 Zevalin-beam conditioning therapy by autologous peripheral stem cell transplantation in follicular non-Hodgkin lymphoma patients (2007) (0)
[Fatal thrombotic microangiopathy in the mother and fetus]. (1990) (0)
[Recommendation: Hodgkin disease] (2001) (0)
[Correlation between thrombocytes and fibrinolysis]. (1994) (0)
[Fibrinolysis in chronic liver diseases studied by in vitro blood coagulation tests]. (1994) (0)
P108 Central nervous system blastic phase in chronic myeloid leukaemia during imatinib treatment (2007) (0)
Thrombotic haemostatic alterations following streptokinase treatment of acute myocardial infarction (1990) (0)
[Molecular biology examination in chronic lymphocytic leukemia]. (2001) (0)
[Comments about dosing of low molecular weight heparins (LMWH)]. (2001) (0)
Effects of beta blockers on glycogen content of the damaged liver (1978) (0)
[The role and significance of the most important known cytokines in inflammatory bowel diseases]. (1998) (0)
P076 Identification of FLT3-ITD mutations in AML patients using different diagnostic methods (2007) (0)
[Insulin receptors of thrombocyte membranes in non-insulin dependent diabetes]. (1984) (0)
[Thrombotic microangiography (thrombotic thrombocytopenic purpura and hemolytic uremia syndrome)]. (1989) (0)
P071 Exploring WILMS tumour gene in acute leukemias initial experiences (2007) (0)
Antiplatelet effects of low-dose aspirin “astrix” therapy (1995) (0)
[Lyell syndrome in a patient with Cushing disease]. (1981) (0)
P114 JAK2 mutation in polycythaemia vera and essential thrombocythaemia (2007) (0)
[Correlation between juvenile-type obesity and puberal basophilism]. (1986) (0)
[Chronic myeloid leukemia]. (2005) (0)
[Galactorrhea induced by metoclopramid]. (1983) (0)
[Primary hemostasis studies in Conn syndrome]. (1992) (0)
[Detection of minimal residual diseases in B-cell tumors using PCR specific for the immunoglobulin heavy chain gene]. (2000) (0)
[Idiopathic refractory sideroblastic anemia, with special reference to diagnosis and clinical course]. (1984) (0)
P130 Angiogenic factor levels in bone marrow and serum of multiple myeloma patients are not applicable to predict response to chemotherapy (2007) (0)
[Fluorescence in situ hybridization in the diagnosis and follow-up of chronic myelogenous leukemia]. (2000) (0)
[Rare cases of primary hyperparathyroidism]. (1991) (0)

This paper list is powered by the following services:

Other Resources About Miklos Udvardy

en.wikipedia.org

What Schools Are Affiliated With Miklos Udvardy?

Miklos Udvardy is affiliated with the following schools:

Miklos Udvardy's Academic­Influence.com Rankings